K. W.
- Country
- Belgium
- Department
- Hematology
Research Overview
- HOVON 165 CLL: A prospective randomized phase I/II trial of venetoclax treatment (26 cycles) with 6 cycles or 12 cycles of epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or Small Lymphocytic Lymphoma. AETHER study (ABT199 + Epcoritamab THErapy for Relapsed/refractory CLL/SLL)
- Phase II Multicenter Trial of Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia with/without TP53 Aberrations
- Phase I-II Study of Brentuximab Vedotin with R-DHAP in CD30+ Diffuse Large B-Cell Lymphoma Refractory or Relapsed Post-First-Line Chemotherapy
Data & Insights
Has run more than one trial at 25 of 74 partner sites.
Specializations
Leukemia Research
The investigator specializes in treating various forms of leukemia, with particular focus on acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). Their research encompasses innovative therapeutic approaches using targeted medications and combination therapies.
- AML treatment with IDH1/IDH2 mutation targeting
- Novel CLL therapy combinations
- B-cell acute lymphoblastic leukemia interventions
Lymphoma Studies
The investigator conducts research in various lymphoma subtypes, including Burkitt lymphoma, diffuse large B-cell lymphoma (DLBCL), and Hodgkin lymphoma. Their work focuses on developing more effective treatment protocols.
- DLBCL treatment optimization
- CAR T-cell therapy applications
- Novel combination therapies for lymphoma
Multiple Myeloma and Blood Disorders
The investigator explores treatments for multiple myeloma and related conditions, including myelodysplastic syndrome and myelofibrosis. Their research involves both established and experimental therapeutic approaches.
- High-risk smoldering multiple myeloma treatment
- Myelofibrosis management strategies
- Cold agglutinin disease interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.